Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Thiosulfate may help hair grow faster in mice and works well with a common hair growth treatment.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Clascoterone is safe for the heart, even at high doses.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Clascoterone safely promotes hair growth similar to minoxidil.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Certain growth factors can promote hair growth in mice by activating hair growth-related proteins.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New drug shows promise for better hair growth in baldness treatment.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.